Your browser doesn't support javascript.
loading
Artificial Intelligence-based Coronary Stenosis Quantification at Coronary CT Angiography versus Quantitative Coronary Angiography.
Dundas, James; Leipsic, Jonathon A; Sellers, Stephanie; Blanke, Philipp; Miranda, Patricia; Ng, Nicholas; Mullen, Sarah; Meier, David; Akodad, Mariama; Sathananthan, Janarthanan; Collet, Carlos; de Bruyne, Bernard; Muller, Olivier; Tzimas, Georgios.
Afiliação
  • Dundas J; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Leipsic JA; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Sellers S; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Blanke P; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Miranda P; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Ng N; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Mullen S; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Meier D; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Akodad M; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Sathananthan J; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Collet C; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • de Bruyne B; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Muller O; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
  • Tzimas G; From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, M
Radiol Cardiothorac Imaging ; 5(6): e230124, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38166336
ABSTRACT
Purpose To evaluate the performance of a new artificial intelligence (AI)-based tool by comparing the quantified stenosis severity at coronary CT angiography (CCTA) with a reference standard derived from invasive quantitative coronary angiography (QCA). Materials and Methods This secondary, post hoc analysis included 120 participants (mean age, 59.7 years ± 10.8 [SD]; 73 [60.8%] men, 47 [39.2%] women) from three large clinical trials (AFFECTS, P3, REFINE) who underwent CCTA and invasive coronary angiography with QCA. Quantitative analysis of coronary stenosis severity at CCTA was performed using an AI-based coronary stenosis quantification (AI-CSQ) software service. Blinded comparison between QCA and AI-CSQ was measured on a per-vessel and per-patient basis. Results The per-vessel AI-CSQ diagnostic sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 80%, 88%, 86%, 65%, and 94%, respectively, for diameter stenosis (DS) 50% or greater; and 78%, 92%, 91%, 47%, and 98%, respectively, for DS 70% or greater. The areas under the receiver operating characteristic curve (AUCs) to predict DS of 50% or greater and 70% or greater on a per-vessel basis were 0.92 (95% CI 0.88, 0.95; P < .001) and 0.93 (95% CI 0.89, 0.97; P < .001), respectively. The AUCs to predict DS of 50% or greater and 70% or greater on a per-patient basis were 0.93 (95% CI 0.88, 0.97; P < .001) and 0.88 (95% CI 0.81, 0.94; P < .001), respectively. Conclusion AI-CSQ at CCTA demonstrated a high diagnostic performance compared with QCA both on a per-patient and per-vessel basis, with high sensitivity for stenosis detection. Keywords CT Angiography, Cardiac, Coronary Arteries Supplemental material is available for this article. Published under a CC BY 4.0 license.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose Coronária / Angiografia por Tomografia Computadorizada Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Radiol Cardiothorac Imaging Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose Coronária / Angiografia por Tomografia Computadorizada Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Radiol Cardiothorac Imaging Ano de publicação: 2023 Tipo de documento: Article